EMCR Symposium

Dr. Eino Solje is an Associate Professor (tenure track) of Clinical Research at the University of Eastern Finland, Director of the Brain Research Unit, and Chief Neurologist of the Memory Center at Kuopio University Hospital. His research focuses on frontotemporal dementia (FTD), with particular expertise in C9orf72-associated disease. He also leads the national DEGE-RWD early-onset dementia real-world project. He heads the Frontotemporal Lobar Degeneration and Early Onset Dementia research group and is actively involved in several international consortia, including GENFI and NIC-FTD.

Dr. Maura Malpetti is an Assistant Research Professor and Race Against Dementia Alzheimer’s Research UK Fellow at the University of Cambridge and an Emerging Leader at the UK Dementia Research Institute. She trained at Vita-Salute San Raffaele University and University of Cambridge, and as visiting researcher at UCSF and LMU Munich. Her research focuses on PET imaging and fluid biomarkers to study frontotemporal dementia, aiming to identify markers and therapeutic targets for early diagnosis and treatment. She leads the Open Network for Frontotemporal Dementia Inflammation Research (ON-FIRE) study, connecting 20+ UK centres to accelerate clinical research in FTD.

Dr. Suvarna Alladi is a Professor of Neurology at the National Institute of Mental Health and Neurosciences in Bangalore, India, where she coordinates a multidisciplinary service for persons living with dementia.

David Foxe is a post‑doctoral researcher with the FRONTIER Research Group at the Brain and Mind Centre, University of Sydney. He has a background in clinical neuropsychology and over 15 years of experience in dementia research. His work focuses on improving the diagnostic process and clinical experience of people with neurodegenerative conditions. David has a particular interest in primary progressive aphasia (PPA); his doctoral research examined ways to improve both diagnosis and management for individuals living with PPA.

Dr. Gringberd is a neuropathologist (MD/PhD) with specialized training in clinical aspects of dementia and neuroanatomy. Her research focuses on neurodegenerative diseases, emphasizing their early, pre-symptomatic stages. After completing a residency in Pathology, she pursued a PhD in Neuropathology of Aging and Dementia, a research-oriented fellowship in Aging Neurology, and a post-doc in Neuroanatomy. She has a strong record of funding and publication, investigating neuropathological aspects of Alzheimer’s disease, tauopathies, and other age-related dementias, with a particular emphasis on early disease mechanisms, selective vulnerability, and deep phenotyping using histological and morphological methods. She founded and co-directed a prolific population-based brain bank specializing in age-related brain conditions in São Paulo, Brazil. I co-lead the UCSF/MAC Neuropathology Core and Neurodegenerative Disease Brain Bank within the UCSF Alzheimer’s Disease (AD) Research Center and lead the Neuropathological Core for the NIA-funded U01 LEADS project. Additionally, she directs a human validation core of an NINDS/U54 Center Without Walls for Tau Biology. Beyond her research, she conducts brain autopsies, provides diagnostic reports for neurodegenerative diseases, consults for extramural institutions, and actively participates in workgroups establishing diagnostic criteria for these conditions. She has a particular interest in tau deposition effects in the neuromodulatory subcortical system and have authored several papers on this topic. She is also the founder and first chair of the Neuromodulatory Subcortical Systems Professional Interest Area. In May 2025, she relocated with her whole lab to the Mayo clinics in Florida. She will also direct an initiative to modernize the Mayo’s Department of Neuroscience’s Brain Bank.

Joaquín Migeot is a researcher at the Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, where he leads research at the intersection of social neuroscience, cognitive aging, and equity in brain health across Latin America. He is also an Global Brain Health Institute (GBHI) Atlantic Fellow for Equity in Brain Health. He has authored over 25 peer-reviewed publications in leading international journals, including Nature Medicine, Nature Communications, Nature Aging, Trends in Neurosciences, and Alzheimer’s & Dementia. His work integrates social determinants of health, exposome science, and neurobiological markers to understand how structural inequality and lived environments shape brain aging and dementia risk. Methodologically, he combines multimodal neuroimaging, biomarkers, and advanced statistical and machine-learning approaches to model mechanisms linking adversity, allostatic load, interoceptive dysfunction, and neurocognitive decline. He contributes to large-scale regional collaborations, including the ReDLat Consortium, where he leads the integration and analysis of social, clinical, cognitive, and neuroimaging datasets across multiple Latin American countries. His contributions span empirical, theoretical, and meta-analytic work aimed at advancing equitable brain health and reducing disparities in dementia outcomes.